42 related articles for article (PubMed ID: 29231991)
21. A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
Zhu M; Cai J; Wu Y; Wu X; Feng L; Yin Z
Med Sci Monit; 2021 Jan; 27():e928195. PubMed ID: 33471782
[TBL] [Abstract][Full Text] [Related]
22. Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study.
Dai ZH; Wang QW; Zhang QW; Yan XL; Aparicio T; Zhou YY; Wang H; Zhang CH; Zaanan A; Afchain P; Zhang Y; Chen HM; Gao YJ; Ge ZZ
EBioMedicine; 2020 Oct; 60():102979. PubMed ID: 32980692
[TBL] [Abstract][Full Text] [Related]
23. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
[TBL] [Abstract][Full Text] [Related]
24. A validated survival nomogram for early-onset diffuse gastric cancer.
Liao F; Guo X; Lu X; Dong W
Aging (Albany NY); 2020 Jul; 12(13):13160-13171. PubMed ID: 32639946
[TBL] [Abstract][Full Text] [Related]
25. Deimination Protein Profiles in
Criscitiello MF; Kraev I; Petersen LH; Lange S
Front Immunol; 2020; 11():651. PubMed ID: 32411128
[TBL] [Abstract][Full Text] [Related]
26. FARP1 boosts CDC42 activity from integrin αvβ5 signaling and correlates with poor prognosis of advanced gastric cancer.
Hirano T; Shinsato Y; Tanabe K; Higa N; Kamil M; Kawahara K; Yamamoto M; Minami K; Shimokawa M; Arigami T; Yanagita S; Matushita D; Uenosono Y; Ishigami S; Kijima Y; Maemura K; Kitazono I; Tanimoto A; Furukawa T; Natsugoe S
Oncogenesis; 2020 Feb; 9(2):13. PubMed ID: 32029704
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival.
Díaz Del Arco C; Estrada Muñoz L; Molina Roldán E; Cerón Nieto MÁ; Ortega Medina L; García Gómez de Las Heras S; Fernández Aceñero MJ
Virchows Arch; 2018 Dec; 473(6):687-695. PubMed ID: 30140949
[TBL] [Abstract][Full Text] [Related]
28. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy.
Lu J; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX
Surg Oncol; 2013 Sep; 22(3):167-71. PubMed ID: 23787074
[TBL] [Abstract][Full Text] [Related]
29. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
[TBL] [Abstract][Full Text] [Related]
30. A DNA methylation signature to improve survival prediction of gastric cancer.
Peng Y; Wu Q; Wang L; Wang H; Yin F
Clin Epigenetics; 2020 Jan; 12(1):15. PubMed ID: 31959204
[TBL] [Abstract][Full Text] [Related]
31. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
32. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
[TBL] [Abstract][Full Text] [Related]
33. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
[TBL] [Abstract][Full Text] [Related]
34. Combination of TNM staging and pathway based risk score models in patients with gastric cancer.
Zhou YY; Kang YT; Chen C; Xu FF; Wang HN; Jin R
J Cell Biochem; 2018 Apr; 119(4):3608-3617. PubMed ID: 29231991
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
